Refractory status epilepticus responding to lidocaine: a case report
[1] Canas N, Delgado H, Silva V, Pinto AR, Sousa S, Simões R, et al. The electroclinical spectrum, etiologies, treatment and outcome of nonconvulsive status epilepticus in the elderly. Epilepsy Behav 2017;79:53-7.
[2] Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012;17:3-23.
[3] Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia 1994;35:27-34.
[4] DeLorenzo RJ, Ko D, Towne AR, Garnett LK, Boggs JG, Waterhouse EJ, et al. Prediction of outcome in status epilepticus. Epilepsia 1997;38(suppl 8):210-5.
[5] Riviello JJ Jr, Claassen J, LaRoche SM, Sperling MR, Alldredge B, Bleck TP, et al. Treatment of status epilepticus: an international survey of experts. Neurocrit Care 2013;18:193-200.
[6] Lempl Y, Eshel Y, Gilad R, Sarova-Pinchas I. Chloral hydrate in intractable status epilepticus. Ann Emerg Med 1990;19:674-6.
[7] Knake S, Gruener J, Hattemer K, Klein KM, Bauer S, Oertel WH, et al Intravenous levetiracetam in the treatment of benzodiazepine-refractory status epilepticus. J Neurol Neurosurg Psychiatry 2008;79:588-9.
[8] Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 2007;16:527-32.
[9] Mori K, Ito H, Toda Y, Hashimoto T, Miyazaki M, Saijo T, et al. Successful management of intractable epilepsy with lidocaine tapes and continuous subcutaneous lidocaine infusion. Epilepsia 2004;45:1287-90.

Copyright (c) 2018 The European Research Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Downloads
Article Information
- Article Type Case Report
- Submitted February 21, 2026
- Published July 3, 2018
- Issue Vol. 4 No. 3 (2018)
- Section Case Report